DHCR7
Basic information
Region (hg38): 11:71428193-71452868
Previous symbols: [ "SLOS" ]
Links
Phenotypes
GenCC
Source:
- Smith-Lemli-Opitz syndrome (Definitive), mode of inheritance: AR
- Smith-Lemli-Opitz syndrome (Strong), mode of inheritance: AR
- Smith-Lemli-Opitz syndrome (Definitive), mode of inheritance: AR
- Smith-Lemli-Opitz syndrome (Definitive), mode of inheritance: AR
- Smith-Lemli-Opitz syndrome (Supportive), mode of inheritance: AR
- Smith-Lemli-Opitz syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Smith-Lemli-Opitz syndrome | AR | Biochemical | Though the data are not definitive, anecdotal reports suggest that cholesterol supplementation and medical treatment (eg, with statins) may be clinically beneficial; Awareness of the potential for multiple malformations (some of which may be occult) may be beneficial to allow prompt recognition and management | Biochemical; Cardiovascular; Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Renal | 14119520; 3812577; 8209913; 7632194; 7684480; 8831138; 8863875; 9024557; 9024564; 9024565; 9024566; 9130950; 9653161; 9683618; 11562938; 9634533; 9683613; 11161831; 10946022; 10951458; 11223857; 11167696; 12366604; 12407710; 15192627; 16761297; 17497248; 20301322; 18285838; 19430384; 20635399; 19365639; 20014133; 23042628; 23072947; 23162303; 23293579; 23319240; 23321614; 23426833; 23532938; 23538569; 23595802; 23688395; 23790112 |
ClinVar
This is a list of variants' phenotypes submitted to
- Smith-Lemli-Opitz_syndrome (899 variants)
- not_provided (224 variants)
- Inborn_genetic_diseases (184 variants)
- not_specified (89 variants)
- DHCR7-related_disorder (80 variants)
- See_cases (3 variants)
- Elevated_circulating_7-dehydrocholesterol_concentration (2 variants)
- Microcephaly (2 variants)
- Small_for_gestational_age (2 variants)
- Primary_microcephaly (2 variants)
- 2-3_toe_syndactyly (2 variants)
- Hepatoblastoma (2 variants)
- Abnormal_brain_morphology (1 variants)
- Intellectual_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHCR7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001360.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 291 | 4 | 308 | ||
| missense | 18 | 135 | 264 | 13 | 2 | 432 |
| nonsense | 25 | 28 | 1 | 54 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 25 | 23 | 2 | 50 | ||
| splice donor/acceptor (+/-2bp) | 2 | 26 | 5 | 33 | ||
| Total | 71 | 214 | 285 | 304 | 6 |
Highest pathogenic variant AF is 0.007446436
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DHCR7 | protein_coding | protein_coding | ENST00000355527 | 7 | 24676 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124575 | 0 | 1173 | 125748 | 0.00468 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.452 | 322 | 300 | 1.07 | 0.0000214 | 3082 |
| Missense in Polyphen | 134 | 119.84 | 1.1182 | 1281 | ||
| Synonymous | -1.88 | 159 | 132 | 1.21 | 0.00000999 | 947 |
| Loss of Function | 0.308 | 20 | 21.5 | 0.928 | 9.42e-7 | 221 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00460 | 0.00432 |
| Ashkenazi Jewish | 0.0128 | 0.0122 |
| East Asian | 0.000273 | 0.000272 |
| Finnish | 0.00252 | 0.00199 |
| European (Non-Finnish) | 0.00800 | 0.00743 |
| Middle Eastern | 0.000273 | 0.000272 |
| South Asian | 0.000459 | 0.000457 |
| Other | 0.00636 | 0.00604 |
dbNSFP
Source:
- Function
- FUNCTION: Production of cholesterol by reduction of C7-C8 double bond of 7-dehydrocholesterol (7-DHC).;
- Pathway
- Steroid biosynthesis - Homo sapiens (human);Vitamin D Metabolism;Cholesterol Biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Squalene and cholesterol biosynthesis;Metabolism;cholesterol biosynthesis III (via desmosterol);cholesterol biosynthesis II (via 24,25-dihydrolanosterol);superpathway of cholesterol biosynthesis;Metabolism of steroids;cholesterol biosynthesis I;Cholesterol biosynthesis via desmosterol;Steroids metabolism;Cholesterol biosynthesis via lathosterol;Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP)
(Consensus)
Recessive Scores
- pRec
- 0.322
Intolerance Scores
- loftool
- 0.0387
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.89
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- blood vessel development;cholesterol biosynthetic process;post-embryonic development;sterol biosynthetic process;brassinosteroid biosynthetic process;cell differentiation;lung development;cholesterol biosynthetic process via desmosterol;cholesterol biosynthetic process via lathosterol;multicellular organism growth;regulation of cell population proliferation;regulation of cholesterol biosynthetic process;oxidation-reduction process
- Cellular component
- nuclear outer membrane;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;membrane;integral component of endoplasmic reticulum membrane
- Molecular function
- sterol delta7 reductase activity;7-dehydrocholesterol reductase activity;NADP binding